BMJ  2004;328:249 (31 January), doi:10.1136/bmj.37995.435787.A6 (published 23 January 2004)

Paper

Clinical efficacy of antiretroviral combination therapy based on protease inhibitors or non-nucleoside analogue reverse transcriptase inhibitors: indirect comparison of controlled trials

¹ Service Universitaire des Maladies Infectieuses et du Voyageur, Centre Hospitalier de Tourcoing, Faculté de Médecine de Lille, BP 619, F 59208 Tourcoing, France, ² Department of Social Medicine, University of Bristol, ³ Department of Social and Preventive Medicine, University of Bern, Switzerland, ⁴ INSERM U593, Bordeaux, France

Objective To compare the clinical efficacy of triple antiretroviral regimens based on protease inhibitors and non-nucleoside analogue reverse transcriptase inhibitors (NNRTIs) in adults positive for antibodies to HIV-1.

Design Systematic review and meta-analysis using indirect comparisons of clinical trials comparing three drug regimens based on two nucleoside reverse transcriptase inhibitors (NRTIs) and either a protease inhibitor or an NNRTI with two drug regimens (two NRTIs). Participants had no previous exposure to protease inhibitors or NNRTIs.

Data sources Medline, the Cochrane controlled trials register, Aidstrials, Aidsdrugs, conference proceedings, and trial registers.

Main outcome measure Progression to AIDS or death.

Results 14 trials, totalling 6785 patients, were identified. Most patients had been exposed to an NRTI and had advanced immunodeficiency at baseline; 1096 progressed to AIDS or died. Seven trials assessed protease inhibitors based triple regimens and seven assessed NNRTI based triple regimens (nevirapine or delavirdine). Triple therapy was more effective than dual therapy. The effect was pronounced for protease inhibitor based regimens (odds ratio 0.49, 95% confidence interval 0.41 to 0.58) but non-significant for NNRTI based regimens (0.90, 0.71 to 1.15). Indirect comparison of the two regimens gave an odds ratio of 0.54 (0.49 to 0.73) in favour of protease inhibitor based treatments. Increases in CD4 cell counts were smaller and suppression of viral replication less with NNRTI based regimens.

Conclusions Indirect evidence shows that protease inhibitor based triple regimens are superior to regimens based on the NNRTIs nevirapine and delavirdine in patients with advanced immunodeficiency who have been exposed to NRTIs. Large trials with clinical end points are required.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Related Articles

Simultaneous comparison of multiple treatments: combining direct and indirect evidence

Deborah M Caldwell, A E Ades, and J P T Higgins
BMJ 2005 331: 897-900. [Extract] [Full Text] [PDF]

Triple therapy is the best treatment for some HIV patients
BMJ 2004 328: 0. [Full Text] [PDF]

Access to antiretroviral treatment in Africa

Rene Loewenson and David McCoy
BMJ 2004 328: 241-242. [Extract] [Full Text] [PDF]

Indirect comparisons: a novel approach to assessing the effect of anti-HIV drugs

Jens D Lundgren and Andrew N Phillips
BMJ 2004 328: 253. [Full Text] [PDF]

Antiretroviral therapy in Africa

Warren Stevens, Steve Kaye, and Tumani Corrah
BMJ 2004 328: 280-282. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Held, D. M., Kissel, J. D., Saran, D., Michalowski, D., Burke, D. H. (2006). Differential Susceptibility of HIV-1 Reverse Transcriptase to Inhibition by RNA Aptamers in Enzymatic Reactions Monitoring Specific Steps during Genome Replication. J. Biol. Chem. 281: 25712-25722 [Abstract] [Full text]  
• Caldwell, D. M, Ades, A E, Higgins, J P T (2005). Simultaneous comparison of multiple treatments: combining direct and indirect evidence. BMJ 331: 897-900 [Full text]  
• Ioannidis, J. P. A. (2005). Contradicted and Initially Stronger Effects in Highly Cited Clinical Research. JAMA 294: 218-228 [Abstract] [Full text]  
• Santaguida, P. L., Helfand, M., Raina, P. (2005). Challenges in Systematic Reviews That Evaluate Drug Efficacy or Effectiveness. ANN INTERN MED 142: 1066-1072 [Abstract] [Full text]  
• Brophy, J. M., Joseph, L. (2005). Medical Decision Making with Incomplete Evidence--Choosing a Platelet Glycoprotein IIbIIIa Receptor Inhibitor for Percutaneous Coronary Interventions. Med Decis Making 25: 222-228 [Abstract]  
• Mackay, G. A., Liu, Z., Singh, D. K., Smith, M. S., Mukherjee, S., Sheffer, D., Jia, F., Adany, I., Sun, K. H., Dhillon, S., Zhuge, W., Narayan, O. (2004). Protection Against Late-Onset AIDS in Macaques Prophylactically Immunized with a Live Simian HIV Vaccine Was Dependent on Persistence of the Vaccine Virus. J. Immunol. 173: 4100-4107 [Abstract] [Full text]  
• Loewenson, R., McCoy, D. (2004). Access to antiretroviral treatment in Africa. BMJ 328: 241-242 [Full text]  
• Lundgren, J. D, Phillips, A. N (2004). Indirect comparisons: a novel approach to assessing the effect of anti-HIV drugs. BMJ 328: 253-253 [Full text]  

Rapid Responses:

Read all Rapid Responses

Essential Measures To Stop The AIDS Epidemic

Mohammed Ali Al-Bayati
bmj.com, 5 Feb 2004 [Full text]

Re: Essential Measures To Stop The AIDS Epidemic

Peter J Flegg
bmj.com, 6 Feb 2004 [Full text]